TrialAdvances in therapy2020

Multiple-Dose Pharmacokinetics of Ozanimod and its Major Active Metabolites and the Pharmacodynamic and Pharmacokinetic Interactions with Pseudoephedrine, a Sympathomimetic Agent, in Healthy Subjects.

Jonathan Q Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.